Loading…
Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension
The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A...
Saved in:
Published in: | Clinical and experimental hypertension (1993) 2011-08, Vol.33 (5), p.309-315 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13 |
---|---|
cites | cdi_FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13 |
container_end_page | 315 |
container_issue | 5 |
container_start_page | 309 |
container_title | Clinical and experimental hypertension (1993) |
container_volume | 33 |
creator | Sakima, Atsushi Ohshiro, Katsuhiko Nakada, Seigo Yamazato, Masanobu Kohagura, Kentaro Nakamoto, Minori Tana, Takeshi Ohya, Yusuke |
description | The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A/T to a fixed-dose L/H on blood pressure (BP) along with medication adherence and the degree of satisfaction in 91 hypertensive outpatients (mean age, 65.2 ± 9.6 years). After 6 months, a significant BP reduction (132 ± 9/76 ± 10 vs. 126 ± 12/72 ± 11 mm Hg), along with an improvement of attaining target BP (44.0 vs. 61.5%) and that of adherence, were observed. The magnitude of BP reduction in the participants increased their degree of satisfaction more significantly than in the participants who worsened their degree of satisfaction. The estimated glomerular filtration rate and the serum uric acid (UA) level decreased slightly but significantly. The hemoglobin A1c of participants with diabetes mellitus increased slightly but significantly. In conclusion, a switch in therapy from variable-dose, multiple-pill A/T combinations to a fixed-dose, single-pill L/H was effective in decreasing BP and serum UA in Japanese clinical practice. Metabolic side effects of L/H in patients with diabetes mellitus remain to be investigated. |
doi_str_mv | 10.3109/10641963.2010.549260 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3109_10641963_2010_549260</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>879480710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13</originalsourceid><addsrcrecordid>eNp9kcFu1DAURSMEoqXwBwh5xyrFdmIn2YDagdKRikC0sLWc-Lnj4tjBdtROv4WPxdO0SGy6suV37r3Wu0XxmuDDiuDuHcG8Jh2vDinOT6zuKMdPin3CKCs5xvxpvmek3DF7xYsYrzAmNWft82KPEl53jLb7xZ_za5OGjXGX6GIDQU5bpIMf0U8ZjOwtlB99BPRltslMFtA3Yy1KHp2YG1DL7DxrM3c3WfmxN04m411EXqMjd2l8AheNQ-s1-g4DTMkHdGz98AtCRNKpnGvkrVEQkc6j0-0E4U7i3cvimZY2wqv786D4cfLpYnVann39vF4dnZVD3Vap5JLwSktSt03TdLWiWDOqKNVYDSBZxTuOOe81rWTf4rpRnAOHppKKMa6AVAfF28V3Cv73DDGJ0cQBrJUO_BxFm11b3BCcyXohh-BjDKDFFMwow1YQLHa1iIdaxK4WsdSSZW_uA-Z-BPVP9NBDBj4sgHF5CaO89sEqkeTW-qCDdIOJO_tHI97_57ABadNmkAHElZ-Dy_t7_I9_AeeXsVE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>879480710</pqid></control><display><type>article</type><title>Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Sakima, Atsushi ; Ohshiro, Katsuhiko ; Nakada, Seigo ; Yamazato, Masanobu ; Kohagura, Kentaro ; Nakamoto, Minori ; Tana, Takeshi ; Ohya, Yusuke</creator><creatorcontrib>Sakima, Atsushi ; Ohshiro, Katsuhiko ; Nakada, Seigo ; Yamazato, Masanobu ; Kohagura, Kentaro ; Nakamoto, Minori ; Tana, Takeshi ; Ohya, Yusuke</creatorcontrib><description>The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A/T to a fixed-dose L/H on blood pressure (BP) along with medication adherence and the degree of satisfaction in 91 hypertensive outpatients (mean age, 65.2 ± 9.6 years). After 6 months, a significant BP reduction (132 ± 9/76 ± 10 vs. 126 ± 12/72 ± 11 mm Hg), along with an improvement of attaining target BP (44.0 vs. 61.5%) and that of adherence, were observed. The magnitude of BP reduction in the participants increased their degree of satisfaction more significantly than in the participants who worsened their degree of satisfaction. The estimated glomerular filtration rate and the serum uric acid (UA) level decreased slightly but significantly. The hemoglobin A1c of participants with diabetes mellitus increased slightly but significantly. In conclusion, a switch in therapy from variable-dose, multiple-pill A/T combinations to a fixed-dose, single-pill L/H was effective in decreasing BP and serum UA in Japanese clinical practice. Metabolic side effects of L/H in patients with diabetes mellitus remain to be investigated.</description><identifier>ISSN: 1064-1963</identifier><identifier>EISSN: 1525-6006</identifier><identifier>DOI: 10.3109/10641963.2010.549260</identifier><identifier>PMID: 21649528</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>adherence ; Aged ; Angiotensin II Type 1 Receptor Blockers - administration & dosage ; Antihypertensive Agents - administration & dosage ; Blood Pressure - drug effects ; combination therapy ; Drug Combinations ; Female ; Humans ; hydrochlorothiazide ; Hydrochlorothiazide - administration & dosage ; hypertension ; Hypertension - blood ; Hypertension - drug therapy ; Hypertension - physiopathology ; Japan ; losartan ; Losartan - administration & dosage ; Male ; Medication Adherence ; Middle Aged ; Patient Satisfaction ; Sodium Chloride Symporter Inhibitors - administration & dosage</subject><ispartof>Clinical and experimental hypertension (1993), 2011-08, Vol.33 (5), p.309-315</ispartof><rights>2011 Informa Healthcare USA, Inc. 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13</citedby><cites>FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21649528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakima, Atsushi</creatorcontrib><creatorcontrib>Ohshiro, Katsuhiko</creatorcontrib><creatorcontrib>Nakada, Seigo</creatorcontrib><creatorcontrib>Yamazato, Masanobu</creatorcontrib><creatorcontrib>Kohagura, Kentaro</creatorcontrib><creatorcontrib>Nakamoto, Minori</creatorcontrib><creatorcontrib>Tana, Takeshi</creatorcontrib><creatorcontrib>Ohya, Yusuke</creatorcontrib><title>Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension</title><title>Clinical and experimental hypertension (1993)</title><addtitle>Clin Exp Hypertens</addtitle><description>The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A/T to a fixed-dose L/H on blood pressure (BP) along with medication adherence and the degree of satisfaction in 91 hypertensive outpatients (mean age, 65.2 ± 9.6 years). After 6 months, a significant BP reduction (132 ± 9/76 ± 10 vs. 126 ± 12/72 ± 11 mm Hg), along with an improvement of attaining target BP (44.0 vs. 61.5%) and that of adherence, were observed. The magnitude of BP reduction in the participants increased their degree of satisfaction more significantly than in the participants who worsened their degree of satisfaction. The estimated glomerular filtration rate and the serum uric acid (UA) level decreased slightly but significantly. The hemoglobin A1c of participants with diabetes mellitus increased slightly but significantly. In conclusion, a switch in therapy from variable-dose, multiple-pill A/T combinations to a fixed-dose, single-pill L/H was effective in decreasing BP and serum UA in Japanese clinical practice. Metabolic side effects of L/H in patients with diabetes mellitus remain to be investigated.</description><subject>adherence</subject><subject>Aged</subject><subject>Angiotensin II Type 1 Receptor Blockers - administration & dosage</subject><subject>Antihypertensive Agents - administration & dosage</subject><subject>Blood Pressure - drug effects</subject><subject>combination therapy</subject><subject>Drug Combinations</subject><subject>Female</subject><subject>Humans</subject><subject>hydrochlorothiazide</subject><subject>Hydrochlorothiazide - administration & dosage</subject><subject>hypertension</subject><subject>Hypertension - blood</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Japan</subject><subject>losartan</subject><subject>Losartan - administration & dosage</subject><subject>Male</subject><subject>Medication Adherence</subject><subject>Middle Aged</subject><subject>Patient Satisfaction</subject><subject>Sodium Chloride Symporter Inhibitors - administration & dosage</subject><issn>1064-1963</issn><issn>1525-6006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAURSMEoqXwBwh5xyrFdmIn2YDagdKRikC0sLWc-Lnj4tjBdtROv4WPxdO0SGy6suV37r3Wu0XxmuDDiuDuHcG8Jh2vDinOT6zuKMdPin3CKCs5xvxpvmek3DF7xYsYrzAmNWft82KPEl53jLb7xZ_za5OGjXGX6GIDQU5bpIMf0U8ZjOwtlB99BPRltslMFtA3Yy1KHp2YG1DL7DxrM3c3WfmxN04m411EXqMjd2l8AheNQ-s1-g4DTMkHdGz98AtCRNKpnGvkrVEQkc6j0-0E4U7i3cvimZY2wqv786D4cfLpYnVann39vF4dnZVD3Vap5JLwSktSt03TdLWiWDOqKNVYDSBZxTuOOe81rWTf4rpRnAOHppKKMa6AVAfF28V3Cv73DDGJ0cQBrJUO_BxFm11b3BCcyXohh-BjDKDFFMwow1YQLHa1iIdaxK4WsdSSZW_uA-Z-BPVP9NBDBj4sgHF5CaO89sEqkeTW-qCDdIOJO_tHI97_57ABadNmkAHElZ-Dy_t7_I9_AeeXsVE</recordid><startdate>201108</startdate><enddate>201108</enddate><creator>Sakima, Atsushi</creator><creator>Ohshiro, Katsuhiko</creator><creator>Nakada, Seigo</creator><creator>Yamazato, Masanobu</creator><creator>Kohagura, Kentaro</creator><creator>Nakamoto, Minori</creator><creator>Tana, Takeshi</creator><creator>Ohya, Yusuke</creator><general>Informa Healthcare</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201108</creationdate><title>Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension</title><author>Sakima, Atsushi ; Ohshiro, Katsuhiko ; Nakada, Seigo ; Yamazato, Masanobu ; Kohagura, Kentaro ; Nakamoto, Minori ; Tana, Takeshi ; Ohya, Yusuke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>adherence</topic><topic>Aged</topic><topic>Angiotensin II Type 1 Receptor Blockers - administration & dosage</topic><topic>Antihypertensive Agents - administration & dosage</topic><topic>Blood Pressure - drug effects</topic><topic>combination therapy</topic><topic>Drug Combinations</topic><topic>Female</topic><topic>Humans</topic><topic>hydrochlorothiazide</topic><topic>Hydrochlorothiazide - administration & dosage</topic><topic>hypertension</topic><topic>Hypertension - blood</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Japan</topic><topic>losartan</topic><topic>Losartan - administration & dosage</topic><topic>Male</topic><topic>Medication Adherence</topic><topic>Middle Aged</topic><topic>Patient Satisfaction</topic><topic>Sodium Chloride Symporter Inhibitors - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakima, Atsushi</creatorcontrib><creatorcontrib>Ohshiro, Katsuhiko</creatorcontrib><creatorcontrib>Nakada, Seigo</creatorcontrib><creatorcontrib>Yamazato, Masanobu</creatorcontrib><creatorcontrib>Kohagura, Kentaro</creatorcontrib><creatorcontrib>Nakamoto, Minori</creatorcontrib><creatorcontrib>Tana, Takeshi</creatorcontrib><creatorcontrib>Ohya, Yusuke</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental hypertension (1993)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakima, Atsushi</au><au>Ohshiro, Katsuhiko</au><au>Nakada, Seigo</au><au>Yamazato, Masanobu</au><au>Kohagura, Kentaro</au><au>Nakamoto, Minori</au><au>Tana, Takeshi</au><au>Ohya, Yusuke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension</atitle><jtitle>Clinical and experimental hypertension (1993)</jtitle><addtitle>Clin Exp Hypertens</addtitle><date>2011-08</date><risdate>2011</risdate><volume>33</volume><issue>5</issue><spage>309</spage><epage>315</epage><pages>309-315</pages><issn>1064-1963</issn><eissn>1525-6006</eissn><abstract>The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A/T to a fixed-dose L/H on blood pressure (BP) along with medication adherence and the degree of satisfaction in 91 hypertensive outpatients (mean age, 65.2 ± 9.6 years). After 6 months, a significant BP reduction (132 ± 9/76 ± 10 vs. 126 ± 12/72 ± 11 mm Hg), along with an improvement of attaining target BP (44.0 vs. 61.5%) and that of adherence, were observed. The magnitude of BP reduction in the participants increased their degree of satisfaction more significantly than in the participants who worsened their degree of satisfaction. The estimated glomerular filtration rate and the serum uric acid (UA) level decreased slightly but significantly. The hemoglobin A1c of participants with diabetes mellitus increased slightly but significantly. In conclusion, a switch in therapy from variable-dose, multiple-pill A/T combinations to a fixed-dose, single-pill L/H was effective in decreasing BP and serum UA in Japanese clinical practice. Metabolic side effects of L/H in patients with diabetes mellitus remain to be investigated.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>21649528</pmid><doi>10.3109/10641963.2010.549260</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1064-1963 |
ispartof | Clinical and experimental hypertension (1993), 2011-08, Vol.33 (5), p.309-315 |
issn | 1064-1963 1525-6006 |
language | eng |
recordid | cdi_crossref_primary_10_3109_10641963_2010_549260 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | adherence Aged Angiotensin II Type 1 Receptor Blockers - administration & dosage Antihypertensive Agents - administration & dosage Blood Pressure - drug effects combination therapy Drug Combinations Female Humans hydrochlorothiazide Hydrochlorothiazide - administration & dosage hypertension Hypertension - blood Hypertension - drug therapy Hypertension - physiopathology Japan losartan Losartan - administration & dosage Male Medication Adherence Middle Aged Patient Satisfaction Sodium Chloride Symporter Inhibitors - administration & dosage |
title | Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T11%3A57%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Switching%20Therapy%20from%20Variable-Dose%20Multiple%20Pill%20to%20Fixed-Dose%20Single-Pill%20Combinations%20of%20Angiotensin%20II%20Receptor%20Blockers%20and%20Thiazides%20for%20Hypertension&rft.jtitle=Clinical%20and%20experimental%20hypertension%20(1993)&rft.au=Sakima,%20Atsushi&rft.date=2011-08&rft.volume=33&rft.issue=5&rft.spage=309&rft.epage=315&rft.pages=309-315&rft.issn=1064-1963&rft.eissn=1525-6006&rft_id=info:doi/10.3109/10641963.2010.549260&rft_dat=%3Cproquest_cross%3E879480710%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=879480710&rft_id=info:pmid/21649528&rfr_iscdi=true |